Related Experiment Video
Updated: Oct 1, 2026
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis
Yingqian Peng1, Yinan Zhao2, Wenyu Hu3
1Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Objective:
Vigabatrin (VGB) is currently served as an effective adjunctive therapy for patients with partial epilepsy worldwide. In this study, meta-analysis was conducted to comprehensively evaluate the changes in peripapillary retinal nerve fiber layer (RNFL) thickness assessed by optical coherence tomography (OCT) in epilepsy patients who were treated by VGB.
Material And Methods:
Publications on PubMed, Wiley Online Library and the Elsevier Science databases were searched by September 2016. The statistical analysis was performed by RevMan 5.3 software.
Results:
Four studies were identified, and 202 eyes in VGB-exposed patients (VGB group) as well as 162 eyes in patients who never received VGB treatment (NON-VGB group) were included. The studies demonstrated that the total RNFL thickness is attenuated in VGB treated patients (weighted mean differences in μm, WMD=-15.96, 95% CI: -23.69 to -8.23, P<0.0001). RNFL thickness in 3 quadrants were significantly reduced in VGB group: superior (WMD=-18.15, 95% CI: -23.31 to -12.98, P<0.00001), inferior (WMD=-23.19, 95% CI: -32.23 to -14.15, P<0.00001) and nasal (WMD=-19.29, 95% CI: -35.57 to -3.02, P=0.02). However, the temporal RNFL thickness in these two groups showed no significant difference: temporal (WMD=-2.41, 95% CI: -6.67 to 1.85, P=0.27).
Conclusion:
Based on the meta-analysis, RNFL thickness appears to reduce in epilepsy patients who received VGB treatment, and OCT could be a useful tool to help clinicians assessing its retinal toxicity and guiding its dosage.
